(Reuters) -A panel of advisers to the U.S. Food and Drug Administration, wary of the safety of Intercept Pharmaceuticals' oral drug for a type of fatty liver disease, recommended on Friday holding off ...

Case Report Overview of Ceftriaxone-Induced Hepatic Panel Abnormalities Discussion Conclusion References Another case report described an 80-year-old man who was hospitalized with painless cholestatic ...

A multinational, multidisciplinary group of experts has created a consensus document to guide diagnosis, staging and management of adults with alpha-1 antitrypsin deficiency-associated liver disease, ...

The liver is one of the most important regulators of systemic energy metabolism, including the coordinated uptake, storage and release of lipids. Lipid metabolism in the liver ranges from uptake of ...

Fatty liver sounds harmless. But it isn’t. It’s a condition where excess fat builds up in the liver, and over time, it can mess up one of the hardest-working organs in your body. What’s worrying is ...